We hereby submit outcome of the Board Meeting held on 30.05.2025. Kindly take the same on your records.
AMBALALSA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved audited financial results (standalone and consolidated) for Q4 and the full year ended 31 March 2025. Consolidated revenue from operations grew to Rs. 19,618.53 lakh (vs Rs. 17,357.05 lakh last year), but a Rs. 700 lakh exceptional charge for settlement of litigation pulled profit before tax down to Rs. 483.36 lakh (vs Rs. 665.10 lakh). Consolidated net profit slipped to Rs. 493.17 lakh, and Q4 alone posted a small loss of Rs. 26.70 lakh. Standalone PAT for the year improved sharply to Rs. 469.72 lakh (vs Rs. 258.32 lakh). Operating cash flow turned negative at Rs. (1,761.52) lakh vs Rs. 888.73 lakh last year, and cash balance fell from Rs. 1,077.61 lakh to Rs. 489.46 lakh. The Board also appointed RPSS & Co. as Secretarial Auditors for 5 years, reappointed Gautam Joshi & Co. as Internal Auditor for FY26, fixed the 47th AGM for 17 July 2025, and recommended reappointment of directors Mr. Mohal Sarabhai and Mr. Mayur Swadia. Statutory auditors issued an unqualified opinion.
Investors should note mixed signals – top-line growth was healthy but a one-time litigation charge and a swing to negative operating cash flow weighed on profitability. The weak Q4 numbers and cash burn could put pressure on the stock in the near term, though the unqualified audit opinion and stable governance appointments offer some comfort.